Boston type 1 keratoprosthesis;
KPro;
Corneal blindness;
Glaucoma;
Penetrating keratoplasty;
BOSTON TYPE-1 KERATOPROSTHESIS;
I KERATOPROSTHESIS;
OUTCOMES;
COMPLICATIONS;
PROGRESSION;
UNIVERSITY;
ANIRIDIA;
VISION;
D O I:
10.1016/j.jfo.2023.07.023
中图分类号:
R77 [眼科学];
学科分类号:
100212 ;
摘要:
Purpose. - To compare visual and glaucoma outcomes in patients with known glaucoma after a penetrating keratoplasty (PKP) or a Boston Keratoprosthesis Type 1 (KPro) as a second corneal replacement procedure. Design. - Retrospective interventional case series. Participants. - Charts of 141 eyes that underwent either a PKP or KPro at the Centre hospitalier de l'Universit & eacute; de Montr & eacute;al after one failed PKP from 2008 to 2020 were reviewed. Forty-six eyes with preoperative glaucoma were included. Methods. - Data collected included demographics, indication for the initial surgery, best corrected visual acuity (BCVA), concurrent ocular disorders, number of glaucoma medications, need for glaucoma surgery, cup -to-disc ratios (CDRs), mean RNFL thickness, and visual field (VF) characteristics. Primary outcomes were glaucoma progression trends. Secondary outcomes were visual outcomes and need for additional procedures. Results. - Mean follow-up was 4.7 years for the PKP and 7.3 for the KPro group ( P < 0.007). 30.6% of PKP compared to 70.5% of KPro patients were diagnosed with glaucoma preoperatively. Glaucoma worsened similarly in both groups; this is based on an analysis of the number of glaucoma medications, CDR, need for glaucoma surgery, and characteristic VF changes. Patients in the PKP group required significantly more regrafts than patients in the KPro group (31.8 vs. 8.3%; P = 0.045). Conclusions. - A preoperative diagnosis of glaucoma does not preclude KPro implantation. In glaucomatous eyes, the disease progressed similarly in both groups. Since both procedures increase the risk of worsening glaucoma, close follow-up is recommended. KPro may decrease the need for further corneal transplantation surgery. (c) 2023 Elsevier Masson SAS. All rights reserved.
机构:
Massachusetts Eye & Ear, Harvard Med Sch, Dept Ophthalmol, Boston, MA USAMassachusetts Eye & Ear, Harvard Med Sch, Dept Ophthalmol, Boston, MA USA
Sun, Jessica A.
Manz, Sarah N.
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Eye & Ear, Harvard Med Sch, Dept Ophthalmol, Boston, MA USAMassachusetts Eye & Ear, Harvard Med Sch, Dept Ophthalmol, Boston, MA USA
Manz, Sarah N.
Shen, Lucy Q.
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Eye & Ear, Harvard Med Sch, Dept Ophthalmol, Boston, MA USA
Massachusetts Eye & Ear, 243 Charles St, Boston, MA 02114 USAMassachusetts Eye & Ear, Harvard Med Sch, Dept Ophthalmol, Boston, MA USA
机构:
All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, IndiaAll India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India
Panda, A
Pangtey, MS
论文数: 0引用数: 0
h-index: 0
机构:
All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, IndiaAll India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India
Pangtey, MS
Sony, P
论文数: 0引用数: 0
h-index: 0
机构:
All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, IndiaAll India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India